v3.25.1
Stock-Based Compensation SSARs (Details) - Stock Appreciation Rights (SARs) [Member]
$ / shares in Units, shares in Thousands, $ in Millions
12 Months Ended
Apr. 30, 2025
USD ($)
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]  
Outstanding, beginning balance | shares 3,750
Granted | shares 595
Exercised | shares (19)
Forfeited or expired | shares (448)
Outstanding, ending balance | shares 3,878
Exercisable | shares 2,653
Weighted Average Exercise Price [Roll Forward]  
Weighted average exercise price, beginning | $ / shares $ 55.37
Weighted average exercise price, grants in period | $ / shares 44.97
Weighted average exercise price, exercises in period | $ / shares 39.58
Weighted average exercise price, forfeitures and expirations in period | $ / shares 42.98
Weighted average exercise price, ending | $ / shares 55.29
Weighted average exercise price, exercisable | $ / shares $ 53.25
Weighted Average Remaining Contractual Term (years) 4 years 7 months 6 days
Weighted Average Remaining Contractual Term (years) 3 years 1 month 6 days
SSARs outstanding, Aggregate Intrinsic Value | $ $ 0
SSARs exercisable, Aggregate Intrinsic Value | $ $ 0